Use-results survey for Lonsurf combination tablet T15 & Lonsurf combination tablet T20

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1080222608

Enrollment

800

Registered

2014-09-25

Start date

2014-09-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

investigational material(s) Generic name etc : Lonsurf combination tablet T15/T20 INN of investigational material : trifluridine + tipiracil hydrochloride Therapeutic category code : 429 Other antitum

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Unresectable advanced or recurrent colorectal cancer (only if refractory to standard treatments).

Exclusion criteria

Exclusion criteria:

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026